Peritoneal washing cytology

Cytopathology

Volumn 15, Issue 3, 2004, Pages 131-141

  Shield, P ^a  

^a Sullivan Nicolaides Pathology ^*  (Australia)

Author keywords

Cytology; Gynaecological malignancy; Immunocytochemistry; Peritoneal washing; Peritoneum

Indexed keywords

ANALYTIC METHOD; CANCER GRADING; CANCER SCREENING; CELL NUCLEUS; CELL VACUOLE; CYTOLOGY; ENDOMETRIOSIS; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; GYNECOLOGIC CANCER; HUMAN; MEDICAL INFORMATION; MESOTHELIUM CELL; METASTASIS; OVARY; OVARY TUMOR; PERITONEUM; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SALPINGITIS; STAINING; UTERINE CERVIX CANCER; UTERINE TUBE MUCOSA;

CYTOLOGICAL TECHNIQUES; ENDOMETRIAL NEOPLASMS; ENDOMETRIOSIS; EPITHELIUM; FEMALE; HUMANS; OVARIAN NEOPLASMS; PERITONEAL CAVITY; PERITONEAL NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 2942731547     PISSN: 09565507     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2004.00140.x     Document Type: Review

References (62)

1. Keetle WC, Elkin HB. Experience with radioactive colloidal gold in the treatment of ovarian carcinoma. Am J Obstet Gynecol 1956;71:553-68.
2. DeMay RM. The Art and Science of Cytopathology. Chicago: ASCP Press; 1996.
3. Zuna E, Mitchell ML, Mulick KA, Weijchert WM. Cytohistologic correlation of peritoneal washing cytology in gynecologic disease. Acta Cytol 1989;33:327-36.
4. Mulvaney N, Arnstein M, Oster AG. Fallopian tube cytology: a histocorrelative study of 150 washings. Diagn Cytopathol 1997;16:483-8.
5. Wojcik E, Naylor B. 'Collagen balls' in peritoneal washings: prevalence morphology, origin and significance. Acta Cytol 1992;36:466-70.
6. Selvaggi SM. Diagnostic pitfalls of peritoneal washing cytology and the role of cell blocks in their diagnosis. Diagn Cytopathol 2003;28:335-41.
7. Sharifi S, Ducatman BS, Wang HH, Fraser JL. Peritoneal washing cytology is unnecessary in gynecologic surgery for benign diseases. Cancer Cytopathol 1999;87:259-62.
8. Mathew S, Erozan YS. Significance of peritoneal washings in gynecologic oncology: the experience with 901 intraoperative washings at an academic center. Arch Pathol Lab Med 1997;121:604-6.
9. Walts AE. Optimization of the peritoneal lavage. Diagn Cytopathol 1998;18:265-59.
10. Cheng L, Wolf NG, Rose PG, Rodriguez M, Abdul-Karim FW. Peritoneal washing cytology of ovarian tumours of low malignant potential. Correlation with surface ovarian involvement and peritoneal implants. Acta Cytol 1998;42:1091-4.
11. Creasman WT, Rutlidge F. The prognostic value peritoneal cytology in gynecologic malignant disease. Am J Obstet Gynecol 1971;110:773-81.
12. Stewart CJ, Kennedy JH. Peritoneal fluid cytology in serous borderline tumours of the ovary. Cytopathology 1998;9:38-45.
13. Johnson T, Kumur NB, Hopkins M, Hughes JD. Cytologic features of ovarian tumours of low malignant potential in peritoneal fluids. Acta Cytol 1988;32:513-8.
14. Gurley AM, Hidvegi DF, Cajulis RS, Bacus S. Morphologic and morphometric features of low grade serous tumours of the ovary. Diagn Cytopathol 1994;11:220-5.
15. Pisharodi LR, Bedrossian CW. Cytopathology of serous neoplasia of the ovary and the peritoneum: differential diagnosis from mesothelial proliferations. Diagn Cytopathol 1996;15:292-5.
16. Ravinsky E. Cytology of peritoneal washings in gynecologic patients: diagnostic criteria and pitfalls. Acta Cytol 1986;30:8-16.
17. Kashimura M, Matsukuma K, Kamura T, Matsuyama T, Tsukamoto N. Cytologic findings in peritoneal fluids from patients with ovarian serous adenocarcinoma. Diagn Cytopathol 1985;1:13-6.
18. Schofield JB, Krausz T. Serous effusions. Metastatic disease and lymphomas. In: Diagnostic Cytopathology, 2nd edn. Gray W, McKee GT (eds). London: Elsevier Science, 2003, pp 184-5.
19. Harouny VR, Sutton GP, Ehrlich CE et al. The importance of peritoneal cytology in endometrial carcinoma. Obstet Gynecol 1988;72:394-8.
20. Creasman WT, Rutledge F. The prognostic value of peritoneal cytology in gynecologic malignant disease. Am J Obstet Gynecol 1971;110:773-81.
21. Turner DA, Gershenson DM, Atkinson N, Sniege N, Wharton AT. The prognostic significance of peritoneal cytology for stage I endometrial cancer. Obstet Gynecol 1989;74:775-80.
22. Zuna RE, Behrens A. Peritoneal washings in gynecologic cancers: long term follow up of 355 patients. J Natl Cancer Inst 1996;88:980-7.
23. Yazigi R, Piver MS, Blumenson L. Malignant peritoneal cytology as a prognostic indicator in stage I endometrial cancer. Obstet Gynecol 1983;62:359-62.
24. Kennedy AW, Webster KD, Nunez C, Bauer LJ. Pelvic washings for cytologic analysis in endometrial adenocarcinoma. J Reprod Med 1993;38:637-42.
25. Lurain JR, Rumsey NK, Schink JC, Wallemark CB, Chmiel JS. Prognostic significance of positive peritoneal cytology in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol 1989;74:175-9.
26. Ebina Y, Hareyama H, Sakuragh N et al. Peritoneal cytology and its prognostic value in endometrial carcinoma. Int Surg 1997;82:244-8.
27. Gu M, Shi W, Barakat RR, Thaler HT, Saigo PE. Peritoneal washings in endometrial carcinoma. A study of 298 patients with histopathologic correlation. Acta Cytol 2000;44:783-9.
28. Menczer J, Modon M, Goor E. The significance of positive tubal cytology in patients with endometrial adenocarcinoma. Gynecol Oncol 1980;10:249-52.
29. Creasman WT, Lukeman J. Role of the fallopian tube in dissemination of malignant cells in corpus cancer. Cancer 1972;29:456-7.
30. Yonemura Y, Endo Y, Yamaguchi T et al. Mechanisms of the formation of the peritoneal dissemination in gastric cancer. Int J Oncol 1996;8:795-802.
31. Yachida S, Fukushima N, Skamoto M, Matsuno Y, Kosuge T, Hirohashi S. Implications of peritoneal washing cytology in patients with potentially resectable pancreatic cancer. Br J Surg 2002;89:573-8.
32. Kadar N, Homesley HD, Melfatano JH. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease. Gynecol Oncol 1992;46:145-9.
33. Sagawa T, Yamada H, Sakuragi N, Fujimoto S. A comparison between the preoperative and operative findings of peritoneal cytology in patients with endometrial cancer. Asia-Oceana J Obstet Gynecol 1994;20:39-47.
34. Sonada Y, Zerbe M, Smith A, Lin O, Barakat R, Hoskins W. High incidence of positive peritoneal cytology in low risk endometrial cancer treated by laparascopically assisted vaginal hysterectomy. Gynecol Oncol 2001;80:378-82.
35. Yanoh K, Takeshima N, Hirai Y et al. Morphologic analyses of positive peritoneal cytology in endometrial carcinoma. Acta Cytol 1999;43:814-9.
36. Itsuka Y, Kaneshima S, Tanida O, Takeuchi T, Koga S. Intraperitoneal free cancer cells and their viability in gastric cancer. Cancer 1979;44:1476-80.
37. Mulvaney N. Cytohistologic correlation in malignant peritoneal washings. Analysis of 75 malignant washings. Acta Cytol 1996;40:1231-9.
38. Abu-Ghazaleh S, Johnston W, Creasman W. The significance of peritoneal cytology in patients with carcinoma of the cervix. Gynecol Oncol 1984;17:139-43.
39. Ordonez NG. Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous tumours. Am J Surg Pathol 1998;22:1203-14.
40. Tauchi PS, Caraway N, Truong LD, Kaplan AL, Ramzy I. Serous surface carcinoma of the peritoneum: useful role of cytology in differential diagnosis and follow up. Acta Cytol 1996;40:429-36.
41. Burke EC, Karpeh MS, Conlon KC, Brennan MF. Peritoneal lavage cytology in gastric cancer: an independent predictor of outcome. Ann Surg Oncol 1998;5:411-5.
42. Nakajima T, Harashima S, Hirata M, Kajitani T. Prognostic and therapeutic values of peritoneal cytology in gastric cancer. Acta Cytol 1978;22:225-9.
43. Konishi M, Kinoshita T, Nakaghori T, Inoue K, Oda T, Takahashi S. Prognostic value of cytologic examination of peritoneal washings in pancreatic cancer. Arch Surg 2002;137:475-80.
44. Vogel P, Ruschoff J, Kummel S et al. Prognostic value of microscopic peritoneal dissemination: comparison between colon and gastric cancer. Dis Colon Rectum 2000;43:92-100.
45. Martin RGG, Fong Y, DeMatteo RP et al. Peritoneal washings are not predictive of occult peritoneal disease in patients with hilar cholangiocarcinoma. J Am Coll Surg 2001;193:620-5.
46. Sniege N, Fanning CV. Peritoneal washing cytology in women: diagnostic pitfalls and clues for correct diagnosis. Diagn Cytopathol 1992;8:632-42.
47. Ziselman EM, Harkavy SE, Hogen M, West W, Atkinson B. Peritoneal washing cytology: uses and diagnostic criteria in gynecologic neoplasms. Acta Cytol 1984;28:105-10.
48. Stowell SB, Wiley CM, Perez-Reyes M, Powers CN. Cytologic diagnosis of peritoneal fluids: applicability to the laparoscopic diagnosis of endometriosis. Acta Cytol 1997;41:817-22.
49. Sniege N, Fernandez T, Copeland LJ et al. Mullerian inclusions in peritoneal washings. Potential source of error in cytologic diagnosis. Acta Cytol 1986;30:271-6.
50. Sidway MK, Silverberg SG. Endosalpingiosis in female peritoneal washings: a diagnostic pitfall. Int J Gynecol Pathol 1987;6:340-6.
51. Shield PW, Perkins G, Wright RG. Immunocytochemical staining of cytological specimens: how helpful is it? Am J Clin Pathol 1996;105:157-62.
52. Benevalo M, Mottolese M, Cosimelli M et al. Diagnostic and prognostic value of peritoneal immunocytology in gastric cancer. J Clin Oncol 1998;16:3406-11.
53. Juhl H, Stritzel M, Wroblewski A et al. Immunocytochemical detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients. Int J Cancer 1994; 57:333-5.
54. Nakao A, Oshima K, Takeda S et al. Peritoneal washings cytology combined with immunocytochemical staining in pancreatic cancer. Hepato-gastroenterology 1999;46:2974-7.
55. Nomoto S, Nalao A, Kasai Y et al. Peritoneal washing cytology combined with immunocytochemical staining and detecting mutant K-ras in pancreatic cancer: comparison of the sensitivity and availability of various methods. Pancreas 1997;14:126-32.
56. Shield PW, Callan JJ, Devine PL. Markers for metastatic adenocarcinoma in serous effusion specimens. Diagn Cytopathol 1994;11:237-45.
57. Doglioni C, DeiTos AP, Laurino L et al. Calretinin: a novel immunohistochemical marker for mesothelioma. Am J cSurg Pathol 1996;20:1037-104.
58. Doglioni C, Chiodera PL, Furlanettto A et al. Calretinin: a specific marker for evaluation of serous effusions (Abstract). Mod Pathol 1997;10:33A.
59. Gotzos V, Vogt P, Celio MR. The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of epithelial type. Pathol Res Pract 1996;192:137-47.
60. Wieczorek TJ, Krane JF. Diagnostic utility of calretinin immunohistochemistry in cytologic cell block preparations. Cancer Cytopathol 2000;90:312-9.
61. Chhieng DC, Yee H, Schaefer D et al. Calretinin staining pattern aids in the differentiation of mesothelioma from adenocarcinoma in serous effusions. Cancer 2000;25:194-200.
62. Covell JL, Carry JB, Feldman PS. Peritoneal washings in ovarian tumours: potential sources of error in cytologic diagnosis. Acta Cytol 1985;29:310-6.